MAZE · Maze Therapeutics, Inc.
$29.58
-0.84 (-2.76%)
At close · Aug 26
Market Cap
$1.65B
Shares
55.55M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$167.5M
FY2024
Net Income
-$131.12M
-351%
FY2025
Operating Margin
34.38%
FY2024
Diluted EPS
-$3.05
-344%
FY2025
Operating Cash Flow
-$111.94M
-247.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 |
|---|---|---|---|
| — | — | $167.5M | |
| $121.85M | $108.45M | $83.5M | |
| $43.76M | $34.45M | $26.42M | |
| $165.61M | $142.9M | $109.91M | |
| -$145.61M | -$142.9M | $57.59M | |
| — | — | 34.38% | |
| — | -$131.12M | $53.4M | |
| — | $0 | $1.17M | |
| -$133.59M | -$131.12M | $52.23M | |
| — | — | 31.18% | |
| — | -$131.12M | $3.41M | |
| -$134.03M | -$131.01M | $52.23M | |
| USD/shares | — | -$3.05 | $1.42 |
| USD/shares | — | -$3.05 | $1.25 |
| shares | — | 42.98M | 2.4M |
| shares | — | 42.98M | 2.73M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 7.40×
EV/EBIT
—
Peer median 12.45×
P/E (TTM)
—
Peer median 17.78×
Peer medians compare against the 272 similar-size Biotechnology companies (of 534 listed).
Key facts
CIK
1842295
CUSIP
578784100
13F (30d)
151 filings
150 filers
Visit website
Investor relations